• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceDERMABOND (A FORMULATION OF 2-OCTYL CYANOACRYLATE)
Generic NameTissue adhesive for the topical approximation of skin
Regulation Number878.4010
ApplicantCLOSURE MEDICAL CORP.
5265 CAPITAL BLVD.
RALEIGH, NC 27616
PMA NumberP960052
Date Received12/24/1996
Decision Date08/26/1998
Reclassified Date 05/05/2008
Product Code MPN 
Docket Number 98M-0879
Notice Date 10/27/1998
Advisory Committee General & Plastic Surgery
Expedited Review Granted? Yes
Combination ProductNo
Approval Order Statement  
This device is indicated for topical application to hold closed easily approximated skin edges from surgical incisions, including punctures from minimally invasive surgery, and simple, thoroughly cleansed, trauma-induced lacerations. DermaBond(TM) may be used in conjunction with, but not in place of, subcuticular sutures.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
Supplements:  S001 S002 S003 S004 S005 S006 S007 S009 S010 S011 S012 
-
-